Brachytherapy Market Size, Share & Forecast Report - 2026 to 2030

The global brachytherapy market size was valued at over USD 1 billion in 2024 and expected to grow at a significant CAGR of around 7% during the forecast period from 2025 to 2030. The increasing number of cancer cases around the world is a primary factor to drive the market growth. As per latest citing by International Agency for Research on Cancer (IARC), the number of cancer patients is expected to reach at around 24.6 million by 2030 and it is estimated that around 19.3 million new cases are diagnosed as cancer cases in 2020 and 10 million deaths recorded in 2020.

Moreover, the technological advancement and the rising adoption of brachytherapy in developed economies is further expected to fuel the market growth in near future years. The wide use of this therapy to treat prostate, gynecological, and breast cancer is projected to boost the market. However, the lack of skilled professionals and low access to advances products is expected to hinder the market over the forecast period.

Market Outlook:

Industry Trends Shaping the Brachytherapy Market:

The brachytherapy market is being shaped by the growing adoption of minimally invasive cancer treatments and the rising global incidence of cancer, particularly prostate, cervical, and breast cancers. Brachytherapy is gaining preference due to its ability to deliver highly localized radiation doses directly to tumors, minimizing damage to surrounding healthy tissues and reducing side effects compared to external beam radiation therapy (EBRT). The increasing availability of high-dose rate (HDR) brachytherapy systems and image-guided technologies is enhancing treatment precision, improving patient outcomes, and driving wider adoption across oncology centers.

Another key trend is the integration of advanced imaging and planning systems, such as MRI, CT, and ultrasound, which are enabling more personalized and accurate treatment delivery. Additionally, the market is witnessing innovation in isotope development and applicator designs, broadening the scope of brachytherapy across different cancer types. Growing support for outpatient cancer treatments and shorter hospital stays is further fueling demand for brachytherapy, as it offers cost-effectiveness and patient convenience. Regionally, North America and Europe lead adoption due to established cancer care infrastructure, while Asia-Pacific is emerging as a fast-growing market, supported by rising cancer awareness, healthcare investments, and government initiatives to improve access to advanced oncology treatments.

Brachytherapy Market Key Drivers:

• Increasing Incidence of Cancer: The rising incidence of cancer globally, particularly prostate, breast, cervical, and skin cancers, has led to an increased demand for effective cancer treatment options. Brachytherapy offers a targeted and localized radiation therapy approach, making it a preferred treatment modality for certain types of cancers.
• Advantages of Brachytherapy: Brachytherapy provides several advantages over other treatment modalities, such as external beam radiation therapy. It offers precise targeting of tumors while minimizing damage to surrounding healthy tissues, leading to better treatment outcomes and reduced side effects. The benefits of brachytherapy, including its efficacy, shorter treatment duration, and improved quality of life for patients, have driven its adoption.
• Technological Advancements: Technological advancements in imaging, radiation delivery systems, and treatment planning software have improved the precision and effectiveness of brachytherapy. The development of new brachytherapy techniques, such as high-dose rate (HDR) brachytherapy and image-guided brachytherapy, has expanded the applications and increased the acceptance of brachytherapy as a treatment option.
• Growing Demand for Minimally Invasive Procedures: There is an increasing preference for minimally invasive procedures among patients and healthcare providers. Brachytherapy is a minimally invasive treatment option that involves the placement of radioactive sources directly into or near the tumor, minimizing the need for open surgery. The demand for minimally invasive procedures has contributed to the growth of the brachytherapy market.
• Aging Population and Cancer Demographics: The aging population is more prone to developing cancer, and as the global population ages, the incidence of cancer is expected to rise. The demographic shift, along with improved cancer screening and detection, has increased the number of patients eligible for brachytherapy treatment, driving market growth.
• Increasing Healthcare Expenditure: The growth in healthcare expenditure, both in developed and developing countries, has provided better access to advanced cancer treatment options such as brachytherapy. Increased investments in healthcare infrastructure, reimbursement policies, and healthcare funding have facilitated the adoption of brachytherapy as a standard treatment option.
• Regulatory Support and Guidelines: Regulatory bodies and professional organizations have provided guidelines and recommendations for the use of brachytherapy in specific cancer types. The establishment of standards and protocols has improved the quality and consistency of brachytherapy treatments and increased confidence among healthcare professionals, further driving market growth.
• Collaboration and Partnerships: Collaboration between medical device manufacturers, research institutions, and healthcare providers has facilitated the development and commercialization of new brachytherapy products and treatment techniques. Collaborative efforts have contributed to advancements in brachytherapy technologies, expanded treatment options, and driven market growth.

Future Opportunities Shaping the Brachytherapy Market’s Evolution:

The brachytherapy market presents significant opportunities with the rising global cancer burden and the increasing demand for effective, targeted therapies. As the prevalence of cancers such as prostate, breast, cervical, and lung continues to grow, healthcare systems are looking for cost-effective and minimally invasive treatment solutions. Brachytherapy offers strong advantages, including shorter treatment times, lower toxicity, and improved patient quality of life, making it an attractive alternative or complement to external beam radiation therapy. This creates opportunities for wider adoption, particularly in emerging markets, where growing investments in oncology infrastructure and increasing awareness of advanced treatment modalities are driving demand.

Another major opportunity lies in the advancement of imaging technologies and treatment planning systems, which are enabling more precise tumor targeting and better clinical outcomes. The development of novel radioactive isotopes, applicators, and automated afterloading systems also opens new avenues for innovation in brachytherapy devices. Furthermore, the trend toward outpatient-based cancer treatments provides an opportunity for cost savings and increased patient accessibility, expanding the market reach. Collaborations between medical device companies, cancer research institutes, and healthcare providers can accelerate innovation and regulatory approvals, helping to bring next-generation brachytherapy solutions to a wider global patient base.

Market Segments Insights:

The global brachytherapy market is bifurcated into product, dosage type, application, and geography. On the basis of product, the market is further segmented into seeds, applicators & afterloaders, and electronic brachytherapy. The seed segment is accounted to hold the largest market share in 2024 around one-third of the market share in terms of revenue. On the other hand, the electronic brachytherapy segment is anticipated to register the fastest growth rate over the forecast period due to benefits associated with it such as low dose radiation, minimal exposure, and no radioactive wastage.

By application, the market is classified into prostate, gynecological, breast, and other cancers. The prostate cancer segment dominated the global brachytherapy market in 2024 and accounted to hold a major market share around one-third of the market share. in contrast, the breast cancer segment is accounted to grow at the fastest growth rate over the forecast period due to the increasing cases of the breast cancer around the world. According to WCRF, 2,088,849 cancer cases were found as breast cancer globally in 2018.

The brachytherapy comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2025 to 2030. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

Brachytherapy Market Segmentation:

By Product:

• Seeds
• Applicators & Afterloaders
• Electronic Brachytherapy

By Dosage Type:

• HDR Brachytherapy
• LDR Brachytherapy

By Application:

• Prostate Cancer
• Gynecological Cancer
• Breast Cancer
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Geographic Coverage: North America Dominates the Brachytherapy Market

Geographically, North America dominated the global brachytherapy market in 2024 and accounted to hold the largest market share around half of the market share in terms of revenue. The early adoption of new technologies and a well-structured healthcare infrastructure are some major factors to drive the market growth in the region. In contrast, the Asia Pacific is accounted to hold the fastest growth rate over the forecast period due to the increasing number of cancer cases coupled with the largest population area across the globe.

Competition Assessment:

Some of the major players operating in the global brachytherapy market are Varian Medical Systems, Inc., Dickinson & Company, Elekta AB, Becton, and Isoray Medical, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

Key Companies:

• Varian Medical Systems, Inc.
• Dickinson & Company
• Elekta AB
• Becton
• Isoray Medical, Inc.
• CIVCO Medical Solutions
• Eckert & Ziegler BEBIG
• Theragenics Corporation
• iCAD, Inc.
• Isoray Medical, Inc.

Key Questions Answered by Brachytherapy Market Report:

• Global brachytherapy market forecasts from 2025-2030
• Regional brachytherapy market forecasts from 2025-2030 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
• Country-level forecasts from 2025-2030 covering 15 major countries from the aforementioned regions
• Brachytherapy submarket forecasts from 2025-2030 covering the market by product, by dosage type, by application, and geography
• Various industry models such as SWOT analysis, Value Chain Analysis pertaining to market
• Analysis of the key factors driving and restraining the growth of the global, regional and country-level markets from 2025-2030
• Competitive Landscape and market positioning of top 10 players operating in the market